Radiomics analysis of longitudinal DaTscan images for improved progression tracking in Parkinson's disease

P Huang, N Shenkov, S Fotouhi, E Davoodi-Bojd, L Lu… - 2017 - Soc Nuclear Med
412 Objectives: DaTscan is increasingly utilized for diagnostic purposes in suspected
parkinsonian syndromes. We aim to enable additional clinical utility of this modality for …

[HTML][HTML] Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images

A Rahmim, P Huang, N Shenkov, S Fotouhi… - NeuroImage: Clinical, 2017 - Elsevier
No disease modifying therapies for Parkinson's disease (PD) have been found effective to
date. To properly power clinical trials for discovery of such therapies, the ability to predict …

Artificial neural network based outcome prediction in DAT SPECT imaging of Parkinson's disease

J Tang, B Yang, N Shenkov, S Fotouhi, E Davoodi-Bojd… - 2017 - Soc Nuclear Med
292 Objectives: Dopamine transporter (DAT) SPECT imaging has been widely used in the
diagnosis of Parkinson's disease (PD). Compared to visual interpretation of DAT SPECT …

Artificial neural network–based prediction of outcome in Parkinson's disease patients using DaTscan SPECT imaging features

J Tang, B Yang, MP Adams, NN Shenkov… - Molecular imaging and …, 2019 - Springer
Purpose Quantitative analysis of dopamine transporter (DAT) single-photon emission
computed tomography (SPECT) images can enhance diagnostic confidence and improve …

Longitudinal clustering analysis and prediction of Parkinson's disease progression

A Saberi, MR Salmanpour, G Hajianfar, A Rahmim - 2021 - Soc Nuclear Med
1051 Objectives: We aimed to identify distinct disease progression pathways in Parkinson's
disease (PD), making use of clinical and imaging features, towards improved understanding …

Use of deep convolutional neural networks to predict Parkinson's disease progression from DaTscan SPECT images

I Klyuzhin, N Shenkov, A Rahmim, V Sossi - 2018 - Soc Nuclear Med
29 Objectives: Brain SPECT imaging with Ioflupane I123 (DaTscan) is clinically used to
measure the striatal dopamine transporter levels and aid the diagnosis of Parkinson's …

Optimized haralick texture quantification to track Parkinson's disease progression from DAT SPECT images

A Rahmim, Y Salimpour, S Blinder, I Klyuzhin, V Sossi - 2016 - Soc Nuclear Med
428 Objectives To optimize Haralick texture analysis for enhanced quantification of DAT
SPECT images in Parkinson's disease (PD) patients, aiming to investigate the potential of …

Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT images

MP Adams, A Rahmim, J Tang - Computers in Biology and Medicine, 2021 - Elsevier
Abstract Purpose Dopamine transporter (DAT) SPECT imaging is routinely used in the
diagnosis of Parkinson's disease (PD). Our previous efforts demonstrated the use of DAT …

[HTML][HTML] The combination of DAT-SPECT, structural and diffusion MRI predicts clinical progression in Parkinson's disease

S Lorio, F Sambataro, A Bertolino… - Frontiers in aging …, 2019 - frontiersin.org
There is an increasing interest in identifying non-invasive biomarkers of disease severity
and prognosis in idiopathic Parkinson's disease (PD). Dopamine-transporter SPECT (DAT …

Evaluation of an automated atlas-based method for DaTscan™ analysis

A Nelson, J Piper, S Pirozzi, Z Shen - 2013 - Soc Nuclear Med
2068 Objectives To evaluate an automated method for the differentiation of Parkinson9s
Disease (PD) from healthy controls (HC) using DaTscan SPECT. Methods 30 PD and 30 HC …